Dilantin-125



Indications and Reactions:

Role Indications Reactions
Primary
Convulsion 60.6%
Epilepsy 12.0%
Grand Mal Convulsion 5.3%
Pain 3.2%
Anxiety 2.2%
Thrombosis Prophylaxis 1.5%
Blood Cholesterol Increased 1.2%
Convulsion Prophylaxis 1.2%
Diabetes Mellitus 1.2%
Hypertension 1.2%
Asthma 1.1%
Insomnia 1.1%
Partial Seizures 1.1%
Gastrooesophageal Reflux Disease 1.1%
Nausea 1.1%
Blood Cholesterol Abnormal 1.0%
Breakthrough Pain 1.0%
Neuropathy Peripheral 1.0%
Depression 0.9%
Vomiting 0.9%
Stevens-johnson Syndrome 51.1%
Convulsion 13.0%
Drug Hypersensitivity 8.5%
Toxic Epidermal Necrolysis 3.9%
Drug Ineffective 2.5%
Death 2.4%
Weight Increased 2.1%
Hypersensitivity 1.7%
Tremor 1.7%
Weight Decreased 1.6%
Rash 1.5%
Toxicity To Various Agents 1.5%
Grand Mal Convulsion 1.3%
Drug Level Decreased 1.2%
Anticonvulsant Drug Level Decreased 1.1%
Anticonvulsant Drug Level Increased 1.1%
Gingival Disorder 1.0%
Road Traffic Accident 1.0%
Vision Blurred 1.0%
Drug Interaction 0.9%
Secondary
Convulsion 56.2%
Epilepsy 7.2%
Grand Mal Convulsion 5.0%
Headache 4.0%
Anxiety 2.8%
Blood Cholesterol Abnormal 2.8%
Pain 2.5%
Depression 2.1%
Drug Use For Unknown Indication 1.9%
Asthma 1.8%
Gastric Disorder 1.8%
Complex Partial Seizures 1.6%
Cerebrovascular Accident 1.5%
Convulsion Prophylaxis 1.5%
Hypertension 1.5%
Heart Rate Irregular 1.3%
Irritable Bowel Syndrome 1.3%
Thyroid Disorder 1.3%
Arthritis 1.0%
Atrial Fibrillation 1.0%
Stevens-johnson Syndrome 39.1%
Toxic Epidermal Necrolysis 8.9%
Convulsion 6.5%
Weight Increased 5.6%
Toxicity To Various Agents 5.2%
Tremor 5.2%
Anticonvulsant Drug Level Decreased 4.0%
Vision Blurred 3.2%
Drug Hypersensitivity 2.8%
Arthralgia 2.4%
Grand Mal Convulsion 2.4%
Anticonvulsant Drug Level Increased 2.0%
Drug Ineffective 2.0%
Headache 1.6%
Insomnia 1.6%
Neuropathy Peripheral 1.6%
Toothache 1.6%
Viral Rash 1.6%
Accident 1.2%
Amnesia 1.2%
Concomitant
Diarrhoea 20.0%
Drug Use For Unknown Indication 20.0%
Insomnia 20.0%
Pneumonia 20.0%
Sedation 20.0%
Ventricular Tachycardia 100.0%
Interacting
Convulsion 22.9%
Gastric Disorder 9.6%
Epilepsy 6.0%
Neuropathy Peripheral 6.0%
Atrial Fibrillation 4.8%
Dyspnoea 4.8%
Mineral Supplementation 4.8%
Asthma 3.6%
Bladder Disorder 3.6%
Constipation 3.6%
Migraine 3.6%
Multiple Sclerosis 3.6%
Muscle Spasms 3.6%
Nausea 3.6%
Thyroid Disorder 3.6%
Deep Vein Thrombosis 2.4%
Ear Infection 2.4%
Electroencephalogram Abnormal 2.4%
Psychotic Disorder 2.4%
Syncope 2.4%
Convulsion 25.0%
Drug Interaction 15.0%
Oedema Peripheral 15.0%
Ear Infection 10.0%
Suicidal Ideation 10.0%
Visual Impairment 10.0%
Ataxia 5.0%
Incoherent 5.0%
Vertigo 5.0%